
Overview
Hatice Gur is a Pathologist and a Laboratory Medicine provider practicing medicine in Manhasset, New York.
Her clinical expertise encompasses Chronic Myelomonocytic Leukemia (CMML), Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), and Myelofibrosis.
Dr. Gur is board certified in American Board Of Pathology/Anatomic & Clinical and American Board Of Pathology/Hematology. She is actively involved in clinical research, co-authoring 6 peer reviewed articles.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
CUIMC/Presbyterian Hospital And Vanderbilt Clinic
Alejandro Gru, MD is the Leonard C. Harber Professor of Dermatology and Director of Dermatopathology at Columbia University Irving Medical Center. He is also the Director of the Dermatopathology Fellowship and holds a joint appointment with the Pathology & Cell Biology Department. Dr. Gru received his MD from the Universidad de Buenos Aires in Argentina. He completed his internship in Medicine and residency training in Anatomic Pathology, followed by fellowship training in Surgical Pathology, Hematopathology, and Dermatopathology at Washington University School of Medicine in St. Louis. He subsequently joined the faculty at Ohio State University as an Assistant Professor of Pathology and Dermatology prior to moving to the University of Virginia, where he was promoted to Associate Professor and then tenured Professor in the Department of Pathology. At the University of Virginia, he established the first cutaneous lymphoma multidisciplinary program and served as director of the Dermatopathology section and fellowship.Dr. Gru is the current President of the United States Cutaneous Lymphoma Consortium (USCLC) and has led the pathology initiatives of the international study in advanced stage cutaneous lymphomas (PROCLIPI), the USCLC lymphoma registry, and more recently the International T-cell Lymphoma Project (TCP 2.0). He is an associate editor for the Journal of Cutaneous Pathology and Seminars in Diagnostic Pathology. He serves on the editorial board of numerous academic journals, including the Journal of the American Academy of Dermatology, the American Journal of Surgical Pathology, Modern Pathology, and Histopathology, among others. Dr. Gru is highly rated in 33 conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides, Erythroderma, and Tissue Biopsy. Dr. Gru is board certified in Anatomic Pathology, Dermatopathology, and Hematopathology.
Wayne Tam is a Pathologist and a Medical Genetics provider practicing medicine in New Hyde Park, New York. Dr. Tam is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Acute Myeloid Leukemia (AML), and Splenectomy. Dr. Tam is board certified in American Board Of Pathology and American Board Of Pathology/Anatomic Pathology.
Hackensack Meridian Mountainside Medical Center
Adnan Savera is a Pathologist practicing medicine in Montclair, New Jersey. Dr. Savera is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Urothelial Cancer.
Frequently Asked Questions about Dr. Hatice D. Gur
Is Dr. Hatice D. Gur a top-rated expert for Chronic Myelomonocytic Leukemia (CMML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hatice D. Gur is classified as an Experienced expert for Chronic Myelomonocytic Leukemia (CMML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Hatice D. Gur specialize in?
While Dr. Hatice D. Gur is a Pathology, they have specific expertise in Chronic Myelomonocytic Leukemia (CMML), Non-Hodgkin Lymphoma, and Acute Lymphoblastic Leukemia (ALL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pathology.
Does Dr. Hatice D. Gur participate in research or clinical trials?
Yes. Dr. Hatice D. Gur has published 6 articles and abstracts on conditions like Chronic Myelomonocytic Leukemia (CMML). You can view a list of Dr. Hatice D. Gur's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Hatice D. Gur accept my insurance?
Dr. Hatice D. Gur accepts most major insurance plans, including Humana. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)Dr. Gur isExperienced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaDr. Gur isExperienced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Gur isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelomonocytic Leukemia (CMML)

